BioSpace News Archive

Deals

Absolute Antibody and Kerafast Merge to Increase Access to Unique Reagents and Recombinant Antibody Technology

The merger brings together two companies with a shared commitment to improving the selection of research tools available to the scientific community.

February 12, 2018
·
2 min read
Business

Palatin Technologies Reports Second Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on February 12, 2018

Palatin Technologies today announced results for its second quarter ended December 31, 2017.

February 12, 2018
·
17 min read
Business

Bonti Appoints Dr. Jacob Chacko to Board of Directors

Bonti today announced the appointment of Dr. Jacob Chacko to its Board of Directors, effective immediately.

February 12, 2018
·
2 min read
Business

Biostage Appoints to its Scientific Advisory Board Charles S. Cox, Jr., MD

The Scientific Advisory Board’s role is to provide scientific guidance and governance for Biostage’s research and development programs.

February 12, 2018
·
6 min read
Policy

Announcing a Proposed Class Action Settlement Involving All Persons that Purchased Shares of ARIAD Pharma Publicly Traded Common Stock During Settlement Class Period

To participate in the Settlement, you must submit a Claim Form online using the settlement website .

February 12, 2018
·
3 min read
Business

ImmunoMet Appoints Vincent J. O’Neill, M.D., B.Sc., M.R.C.P, as CMO, and Allan L. Shaw as CFO

Dr. O’Neill, a medical oncologist, joins ImmunoMet with 16 years of oncology therapeutic and diagnostic product development experience at both large pharma and biotech companies.

February 12, 2018
·
3 min read
Drug Development

Applied Therapeutics Initiates Phase I Trial for AT-001 In Diabetic Complications

Applied today announced initiation of a Phase 1 clinical trial for AT-001, an oral small molecule in development for diabetic complications.

February 12, 2018
·
1 min read